Pluri Inc.
Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.
PLUR | TA
Overview
Corporate Details
- ISIN(s):
- US72942G2030
- LEI:
- Country:
- Israel
- Address:
- Park Building No. 5, 3508409 Haifa
- Website:
- https://pluri-biotech.com/
- Sector:
- Manufacturing
Description
Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-01 16:15 |
FORM 8-K-Effects of the Reverse Split
|
English | 1.3 MB | ||
| 2024-04-01 16:15 |
FORM 8-K-Effects of the Reverse Split
|
English | 36.3 KB | ||
| 2024-04-01 11:58 |
The capital consolidation not yet been completed in DTC, trading in the company…
|
Hebrew (modern) | 77.5 KB | ||
| 2024-03-28 14:01 |
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Parti…
|
English | 92.8 KB | ||
| 2024-03-28 14:01 |
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Parti…
|
English | 36.3 KB | ||
| 2024-03-27 18:43 |
There will be no trading on March 31, 2024, due a capital consolidation in the …
|
Hebrew (modern) | 77.6 KB | ||
| 2024-03-27 14:01 |
Pluri Inc. Announces 1-for-8 Reverse Share Split
|
English | 89.4 KB | ||
| 2024-03-27 14:01 |
Pluri Inc. Announces 1-for-8 Reverse Share Split
|
English | 36.2 KB | ||
| 2024-03-21 14:01 |
Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in…
|
English | 109.4 KB | ||
| 2024-03-21 14:01 |
Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in…
|
English | 36.2 KB | ||
| 2024-03-19 11:02 |
Announced its participation in upcoming conferences,details
|
English | 109.8 KB | ||
| 2024-03-19 11:02 |
Announced its participation in upcoming conferences,details
|
English | 36.3 KB | ||
| 2024-03-14 14:01 |
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufactu…
|
English | 97.0 KB | ||
| 2024-03-14 14:01 |
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufactu…
|
English | 36.3 KB | ||
| 2024-03-11 14:02 |
Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell …
|
English | 92.9 KB |
Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pluri Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pluri Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
